Literature DB >> 17688500

Confidence intervals and P-values for meta-analysis with publication bias.

Masayuki Henmi1, John B Copas, Shinto Eguchi.   

Abstract

We study publication bias in meta-analysis by supposing there is a population (y, sigma) of studies which give treatment effect estimates y approximately N(theta, sigma(2)). A selection function describes the probability that each study is selected for review. The overall estimate of theta depends on the studies selected, and hence on the (unknown) selection function. Our previous paper, Copas and Jackson (2004, Biometrics 60, 146-153), studied the maximum bias over all possible selection functions which satisfy the weak condition that large studies (small sigma) are as likely, or more likely, to be selected than small studies (large sigma). This led to a worst-case sensitivity analysis, controlling for the overall fraction of studies selected. However, no account was taken of the effect of selection on the uncertainty in estimation. This article extends the previous work by finding corresponding confidence intervals and P-values, and hence a new sensitivity analysis for publication bias. Two examples are discussed.

Mesh:

Substances:

Year:  2007        PMID: 17688500     DOI: 10.1111/j.1541-0420.2006.00705.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  4 in total

1.  Combining information.

Authors:  Walter W Piegorsch; A John Bailer
Journal:  Wiley Interdiscip Rev Comput Stat       Date:  2009-11

2.  Bias towards publishing positive results in orthopedic and general surgery: a patient safety issue?

Authors:  Erik A Hasenboehler; Imran K Choudhry; Justin T Newman; Wade R Smith; Bruce H Ziran; Philip F Stahel
Journal:  Patient Saf Surg       Date:  2007-11-27

Review 3.  False-positive results in cancer epidemiology: a plea for epistemological modesty.

Authors:  Paolo Boffetta; Joseph K McLaughlin; Carlo La Vecchia; Robert E Tarone; Loren Lipworth; William J Blot
Journal:  J Natl Cancer Inst       Date:  2008-07-08       Impact factor: 13.506

4.  SF3B1 mutation is a prognostic factor in chronic lymphocytic leukemia: a meta-analysis.

Authors:  Zhenghao Zhang; Shu Chen; Shuang Chen; Gang Chen; Rui Zhang; Jinhua Li; Jianhua Qu
Journal:  Oncotarget       Date:  2017-07-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.